For cancers involving solid tumors, RECIST criteria are often used to determine how well a patient responds to an experimental treatment in a clinical trial. RECIST, or "Response Evaluation Criteria In Solid Tumors," looks at whether a patient's tumor has disappeared, shrunk, stayed about the same size, or gotten bigger. The patient's doctor measures the tumor using CT scans, MRI images, or PET scans taken before and after treatment. Based on these measurements, researchers can objectively report how each patient responded to a studied treatment.
This is a clip from a Lumination we produced for Cholangiocarcinoma Foundation, called "Understanding Your Clinical Trial Results." For the full video, visit: [ Ссылка ]
To learn more about clinical trials from Cholangiocarcinoma Foundation, visit: [ Ссылка ]
For more Luminations, LIKE this video and SUBSCRIBE: [ Ссылка ]
Interested in producing a Lumination? Visit [ Ссылка ]
#Luminations #ClinicalTrials #Cancer #CholangiocarcinomaFoundation #CancerClinicalTrials #CancerTreatment #PatientEducation #PatientEd
You and your doctor are a team in your care. This video is for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to decide the right course of treatment for you.
About Luminations: Luminations offer an innovative take on patient education videos. Each short educational video is packed with visual metaphors that introduce your audience to new scientific concepts using familiar references. Hand-drawn animation makes our diverse cast of characters more emotive and expressive—and thus more relatable—than traditional explainer patient education videos online. And our lighthearted approach makes it easier for patients to be more open to learning about their disease and treatment.
